166 related articles for article (PubMed ID: 15764169)
21. Synergistic inhibition of SARS-coronavirus replication by type I and type II IFN.
Mossel EC; Sainz B; Garry RF; Peters CJ
Adv Exp Med Biol; 2006; 581():503-6. PubMed ID: 17037585
[No Abstract] [Full Text] [Related]
22. [Anti-SARS virus activities of different recombinant human interferons in cell culture system].
Duan ZJ; Zhang LL; Xie ZP; Yu ZA; Zhang LP; Zhang B; Liu YQ; Wang JW; Li WP; Zhang CH; Ma XJ; Shu YL; Duan SM; Li DX; Hou YD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):205-8. PubMed ID: 15340558
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication.
Li YQ; Li ZL; Zhao WJ; Wen RX; Meng QW; Zeng Y
Eur J Med Chem; 2006 Sep; 41(9):1084-9. PubMed ID: 16875760
[TBL] [Abstract][Full Text] [Related]
24. Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus.
Aguilar PV; Paessler S; Carrara AS; Baron S; Poast J; Wang E; Moncayo AC; Anishchenko M; Watts D; Tesh RB; Weaver SC
J Virol; 2005 Sep; 79(17):11300-10. PubMed ID: 16103182
[TBL] [Abstract][Full Text] [Related]
25. Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-coV).
Chu CK; Gadthula S; Chen X; Choo H; Olgen S; Barnard DL; Sidwell RW
Antivir Chem Chemother; 2006; 17(5):285-9. PubMed ID: 17176633
[TBL] [Abstract][Full Text] [Related]
26. The interferon-stimulated exosomal hACE2 potently inhibits SARS-CoV-2 replication through competitively blocking the virus entry.
Zhang J; Huang F; Xia B; Yuan Y; Yu F; Wang G; Chen Q; Wang Q; Li Y; Li R; Song Z; Pan T; Chen J; Lu G; Zhang H
Signal Transduct Target Ther; 2021 May; 6(1):189. PubMed ID: 33980808
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus.
Saijo M; Morikawa S; Fukushi S; Mizutani T; Hasegawa H; Nagata N; Iwata N; Kurane I
Antiviral Res; 2005 Jun; 66(2-3):159-63. PubMed ID: 15911031
[TBL] [Abstract][Full Text] [Related]
28. Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
Schuhenn J; Meister TL; Todt D; Bracht T; Schork K; Billaud JN; Elsner C; Heinen N; Karakoese Z; Haid S; Kumar S; Brunotte L; Eisenacher M; Di Y; Lew J; Falzarano D; Chen J; Yuan Z; Pietschmann T; Wiegmann B; Uebner H; Taube C; Le-Trilling VTK; Trilling M; Krawczyk A; Ludwig S; Sitek B; Steinmann E; Dittmer U; Lavender KJ; Sutter K; Pfaender S
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35131898
[TBL] [Abstract][Full Text] [Related]
29. Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid.
He R; Adonov A; Traykova-Adonova M; Cao J; Cutts T; Grudesky E; Deschambaul Y; Berry J; Drebot M; Li X
Biochem Biophys Res Commun; 2004 Aug; 320(4):1199-203. PubMed ID: 15249217
[TBL] [Abstract][Full Text] [Related]
30. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.
Haagmans BL; Kuiken T; Martina BE; Fouchier RA; Rimmelzwaan GF; van Amerongen G; van Riel D; de Jong T; Itamura S; Chan KH; Tashiro M; Osterhaus AD
Nat Med; 2004 Mar; 10(3):290-3. PubMed ID: 14981511
[TBL] [Abstract][Full Text] [Related]
31. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.
Chen L; Gui C; Luo X; Yang Q; Günther S; Scandella E; Drosten C; Bai D; He X; Ludewig B; Chen J; Luo H; Yang Y; Yang Y; Zou J; Thiel V; Chen K; Shen J; Shen X; Jiang H
J Virol; 2005 Jun; 79(11):7095-103. PubMed ID: 15890949
[TBL] [Abstract][Full Text] [Related]
32. Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain.
Wathelet MG; Orr M; Frieman MB; Baric RS
J Virol; 2007 Nov; 81(21):11620-33. PubMed ID: 17715225
[TBL] [Abstract][Full Text] [Related]
33. Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus.
Hoever G; Baltina L; Michaelis M; Kondratenko R; Baltina L; Tolstikov GA; Doerr HW; Cinatl J
J Med Chem; 2005 Feb; 48(4):1256-9. PubMed ID: 15715493
[TBL] [Abstract][Full Text] [Related]
34. Coordinate induction of IFN-alpha and -gamma by SARS-CoV also in the absence of virus replication.
Castilletti C; Bordi L; Lalle E; Rozera G; Poccia F; Agrati C; Abbate I; Capobianchi MR
Virology; 2005 Oct; 341(1):163-9. PubMed ID: 16095648
[TBL] [Abstract][Full Text] [Related]
35. Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells.
Kumaki Y; Day CW; Wandersee MK; Schow BP; Madsen JS; Grant D; Roth JP; Smee DF; Blatt LM; Barnard DL
Biochem Biophys Res Commun; 2008 Jun; 371(1):110-3. PubMed ID: 18406349
[TBL] [Abstract][Full Text] [Related]
36. Treatment of SARS with human interferons.
Cinatl J; Morgenstern B; Bauer G; Chandra P; Rabenau H; Doerr HW
Lancet; 2003 Jul; 362(9380):293-4. PubMed ID: 12892961
[TBL] [Abstract][Full Text] [Related]
37. Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells.
Pierce AT; DeSalvo J; Foster TP; Kosinski A; Weller SK; Halford WP
J Gen Virol; 2005 Sep; 86(Pt 9):2421-2432. PubMed ID: 16099899
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide.
Wu CJ; Jan JT; Chen CM; Hsieh HP; Hwang DR; Liu HW; Liu CY; Huang HW; Chen SC; Hong CF; Lin RK; Chao YS; Hsu JT
Antimicrob Agents Chemother; 2004 Jul; 48(7):2693-6. PubMed ID: 15215127
[TBL] [Abstract][Full Text] [Related]
39. HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus.
Yamamoto N; Yang R; Yoshinaka Y; Amari S; Nakano T; Cinatl J; Rabenau H; Doerr HW; Hunsmann G; Otaka A; Tamamura H; Fujii N; Yamamoto N
Biochem Biophys Res Commun; 2004 Jun; 318(3):719-25. PubMed ID: 15144898
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3.
Spiegel M; Pichlmair A; Martínez-Sobrido L; Cros J; García-Sastre A; Haller O; Weber F
J Virol; 2005 Feb; 79(4):2079-86. PubMed ID: 15681410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
